Scrips International Harmonisation Of Pharmaceutical Registration Report PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Scrips International Harmonisation Of Pharmaceutical Registration Report PDF full book. Access full book title Scrips International Harmonisation Of Pharmaceutical Registration Report.
Author | : Vivienne Kendall |
Publisher | : |
Total Pages | : 163 |
Release | : 1994 |
Genre | : Pharmaceutical industry |
ISBN | : |
Download Scrip's International Harmonisation of Pharmaceutical Registration Report Book in PDF, ePub and Kindle
Author | : British Library. Document Supply Centre |
Publisher | : |
Total Pages | : 788 |
Release | : 1995 |
Genre | : Dissertations, Academic |
ISBN | : |
Download British Reports, Translations and Theses Book in PDF, ePub and Kindle
Author | : Agency for Healthcare Research and Quality/AHRQ |
Publisher | : Government Printing Office |
Total Pages | : 385 |
Release | : 2014-04-01 |
Genre | : Medical |
ISBN | : 1587634333 |
Download Registries for Evaluating Patient Outcomes Book in PDF, ePub and Kindle
This User’s Guide is intended to support the design, implementation, analysis, interpretation, and quality evaluation of registries created to increase understanding of patient outcomes. For the purposes of this guide, a patient registry is an organized system that uses observational study methods to collect uniform data (clinical and other) to evaluate specified outcomes for a population defined by a particular disease, condition, or exposure, and that serves one or more predetermined scientific, clinical, or policy purposes. A registry database is a file (or files) derived from the registry. Although registries can serve many purposes, this guide focuses on registries created for one or more of the following purposes: to describe the natural history of disease, to determine clinical effectiveness or cost-effectiveness of health care products and services, to measure or monitor safety and harm, and/or to measure quality of care. Registries are classified according to how their populations are defined. For example, product registries include patients who have been exposed to biopharmaceutical products or medical devices. Health services registries consist of patients who have had a common procedure, clinical encounter, or hospitalization. Disease or condition registries are defined by patients having the same diagnosis, such as cystic fibrosis or heart failure. The User’s Guide was created by researchers affiliated with AHRQ’s Effective Health Care Program, particularly those who participated in AHRQ’s DEcIDE (Developing Evidence to Inform Decisions About Effectiveness) program. Chapters were subject to multiple internal and external independent reviews.
Author | : World Health Organization |
Publisher | : |
Total Pages | : 381 |
Release | : 2001-01-01 |
Genre | : Medical |
ISBN | : 9789290360742 |
Download Current Challenges in Pharmacovigilance Book in PDF, ePub and Kindle
In spite of recent progress in the harmonization of terminology and processes affecting work on the clinical safety of medicines consensus is needed on standards for many difficult aspects of day-to-day pharmacovigilance that continue to pose problems for both the pharmaceutical industry and drug regulators. The CIOMS V Working Group has generated proposals for pragmatic approaches to dealing with such issues as: classification and handling of individual safety case reports from a variety of sources (spontaneous consumer reports solicited reports literature the Internet observational studies and secondary data bases disease and other registries regulatory ADR databases and licensor-licensee interactions); new approaches to case management and regulatory reporting practices (proper clinical evaluation of cases incidental vs other events patient and reporter identifiability seriousness criteria expectedness criteria case follow-up criteria and the role and structure of case narratives); improvements and efficiencies in the format content and reporting of periodic safety update reports (PSURs) (including results of an industry survey on PSUR workloads and practices; proposals for high case volume and long time-period reports simplification of certain PSURs summary bridging reports addendum reports license renewal reports for EU and Japan dealing with old products and other technical details); determination and use of population exposure (denominator) data (sources of data and a guide to analytical approaches for a variety of circumstances).The Group has also taken stock of the current state of expedited and periodic clinical safety reporting requirements around the world with summary data on regulations from more than 60 countries. Recommendations are made for enhancing the harmonization steps already taken as a result of previous CIOMS publications and the ICH process. In addition to dealing with unfinished and unresolved issues from previous CIOMS initiatives the report covers many emerging topics such as those involving new technologies. Its 20 Appendices provide a wealth of detailed explanations and reference information. It is the most comprehensive and recent treatment of difficult pharmacovigilance issues affecting the working practices and systems of drug safety and other pharmaceutical professionals.
Author | : Michael J. Klepper |
Publisher | : Jones & Bartlett Learning |
Total Pages | : 332 |
Release | : 2011 |
Genre | : Medical |
ISBN | : 0763769126 |
Download Drug Safety Data Book in PDF, ePub and Kindle
Drug Safety Data: How to Analyze, Summarize and Interpret to Determine Risk provides pharmaceutical scientists, researchers and technicians with an accessible, practical framework for the analysis, summary and interpretation of drug safety data. The only guide of its kind, Drug Safety Data: How to Analyze, Summarize and Interpret to Determine Risk is an invaluable reference for premarketing risk assessment. This unique resource enhances the ability of pharmaceutical professionalsùthose with and without clinical trainingùto determine the risk of a drug or biologic ahead of its release, thereby reducing unnecessary jeopardy to the patient. Authors Dr. Michael Klepper and Dr. Barton Cobert, who together bring decades of pharmaceutical research and drug safety expertise, discuss how quality planning, safety training and data standardization result in significant cost, time and resource savings. Through illustrative, step-by-step instruction, Drug Safety Data: How to Analyze, Summarize and Interpret to Determine Risk provides the definitive guide to drug safety data analysis and reporting. Key features include: Step-by-step instruction on how to analyze, summarize and interpret safety data for mandatory governmental safety reports Pragmatic tipsàand mistakes to avoid Simple explanations of what safety data are collected, and what the data mean Practical approaches to determining a drug effect and understanding its clinical significance Guidance for determining risk throughout the lifecycle of a drug, biologic or nutraceutical Examples of user-friendly data displays that enhance safety signal identification Ways to improve data quality and reduce the time, resources and costs involved in mandatory safety reporting Relevant material for the required training of drug safety/pharmacovigilance professionals SPECIAL FEATURE: Actual examples of an Integrated Analysis of Safety (IAS) -used in the preparation of the Integrated Summary of Safety (ISS) and the Summary of Clinical Safety (SCS) reports -, and the Periodic Safety Update Report (PSUR)
Author | : Great Britain. Patent Office |
Publisher | : |
Total Pages | : 400 |
Release | : 1994 |
Genre | : Patents |
ISBN | : |
Download Illustrated Official Journal (patents) Book in PDF, ePub and Kindle
Author | : John Abraham |
Publisher | : Routledge |
Total Pages | : 260 |
Release | : 2014-04-04 |
Genre | : Medical |
ISBN | : 1136295720 |
Download Regulating Medicines in Europe Book in PDF, ePub and Kindle
This Book explains and investigates how medicines are controlled in Europe, especially the EU. Based on penetrating documentary and interview research with the pharmaceutical industry, regulators and consumer organisations,it provides the first major critical examination of the new Europeanised systems of medicine regulation. The authors argue that the drive to produce and approve more drugs more quickly for a single European market dominates other considerations, such as improvements in democratic accountability, the independence of regulators and scientific expertise from commercial interests, and drug safety testing and surveillance.
Author | : CIOMS Working Group III |
Publisher | : World Health Organization |
Total Pages | : 98 |
Release | : 1999 |
Genre | : Drugs |
ISBN | : 9789290360704 |
Download Guidelines for Preparing Core Clinical-safety Information on Drugs Book in PDF, ePub and Kindle
Author | : Arthur James Wells |
Publisher | : |
Total Pages | : 1554 |
Release | : 1994 |
Genre | : Bibliography, National |
ISBN | : |
Download The British National Bibliography Book in PDF, ePub and Kindle
Author | : Great Britain: Parliament: House of Commons: Health Committee |
Publisher | : The Stationery Office |
Total Pages | : 556 |
Release | : 2005-04-26 |
Genre | : Political Science |
ISBN | : 9780215024572 |
Download The Influence of the Pharmaceutical Industry Book in PDF, ePub and Kindle
Incorporating HC 1030-i to iii.